Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
Apolipoprotein C-II (APOC2) is an obligatory activator of lipoprotein lipase. Human patients with APOC2 deficiency display severe hypertriglyceridemia while consuming a normal diet, often manifesting xanthomas, lipemia retinalis and pancreatitis. Hypertriglyceridemia is also an important risk factor...
Main Authors: | Chao Liu, Keith P. Gates, Longhou Fang, Marcelo J. Amar, Dina A. Schneider, Honglian Geng, Wei Huang, Jungsu Kim, Jennifer Pattison, Jian Zhang, Joseph L. Witztum, Alan T. Remaley, P. Duc Dong, Yury I. Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2015-08-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/8/8/989 |
Similar Items
-
Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
by: Denis Sviridov, et al.
Published: (2023-07-01) -
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
by: Jan Borén, et al.
Published: (2020-07-01) -
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
by: Bastian Ramms, et al.
Published: (2019-08-01) -
Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
by: Frank G. Schaap, et al.
Published: (2006-10-01) -
Characterization of the plasma lipoproteins of the genetically obese hyperlipoproteinemic Zucker fatty rat
by: Gustav Schonfeld, et al.
Published: (1974-09-01)